Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Heart

No studies found 2 · 28.6%GRADE not reported 0 · 0%Very low 3 · 42.9%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%

All‐cause mortality maximum · patients with acute coronary syndrome

Drug‐eluting stents showed no clear difference in all‐cause mortality at maximum compared with bare‐metal stents (low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.9 [0.78, 1.03]
21 studies · 11250 participants
Low

Serious adverse events maximum · patients with acute coronary syndrome

Drug‐eluting stents may leads to lower serious adverse events at maximum compared with bare‐metal stents (low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.8 [0.74, 0.86]
22 studies · 11724 participants
Low

Major cardiovascular event Physicians · patients with acute coronary syndrome

It is very uncertain whether drug‐eluting stents changes major cardiovascular events at maximum compared with bare‐metal stents (very low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.96 [0.83, 1.11]
19 studies · 10939 participants
Very low

Quality of life at maximum · patients with acute coronary syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cardiovascular mortality · patients with acute coronary syndrome

It is very uncertain whether drug‐eluting stents changes cardiovascular mortality at maximum compared with bare‐metal stents (very low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.91 [0.76, 1.09]
14 studies · 9248 participants
Very low

Myocardial infarction · patients with acute coronary syndrome

It is very uncertain whether drug‐eluting stents changes myocardial infarction at maximum compared with bare‐metal stents (very low certainty).

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
RR 0.98 [0.82, 1.18]
18 studies · 10217 participants
Very low

Angina · patients with acute coronary syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found